ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 573

Synovial Fibroblast-Neutrophil Interactions Promote Pathogenic Adaptive Immunity in Rheumatoid Arthritis

Carmelo Carmona-Rivera1, Erica Moore2, Nithya Lingampalli3, Hannes Uchtenhagen4, Eddie James5, Kevin L. Bicker6, Heidi Wähämaa7, Victoria Hoffmann8, Anca I Catrina7, Paul Thompson9, Jane H. Buckner5, William Robinson10, David Fox11 and Mariana Kaplan2, 1Systemic Autoimmunity Branch/ NIAMS, National Institutes of Health, Bethesda, MD, 2Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Benaroya Research Institute at Virginia Mason, Seattle, WA, 6Middle Tennessee State University, Murfreesboro, TN, 7Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 8Division of Veterinary Resources, National Institutes of Health, Bethesda, MD, 9University of Massachusetts, Worcester, MA, 10Stanford University School of Medicine, Stanford, CA, 11Department of Medicine [Division of Rheumatology], University of Michigan, Ann Arbor, MI

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Autoimmunity, citrullinated vimentin and rheumatoid arthritis (RA), Neutrophil Extracellular Traps

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:   Rheumatoid arthritis (RA) is characterized by development of humoral and cellular autoimmunity to citrullinated proteins and peptides. Autoimmunity to citrullinated antigens appears years before the onset of clinical symptoms of RA Neutrophil extracellular traps (NETs) are a source of citrullinated autoantigens and activate RA synovial fibroblasts (FLS), cells crucial in joint damage. We investigated the molecular mechanisms by which NETs promote proinflammatory phenotypes in FLS, and whether these interactions generate pathogenic anti-citrulline adaptive immune responses.

Methods:   Shared epitope-positive RA FLS and control Osteoarthritis FLS were co-cultured with RA NETs and interactions visualized by confocal microscopy. Induction of inflammatory responses and MHC class II expression were assessed by qPCR. RA-FLS and Ag-specific RA T cells were co-cultured for 5 days and T cell activation was examined. HLADRB1*0401 transgenic mice were immunized with mouse FLS loaded with NETs or FLS alone. Antibodies to citrullinated proteins antigens (ACPAs) were quantified by ELISA, immunoblot and epitope mapping array. Cartilage integrity was assessed by safranin-O staining.

Results:   NETs containing citrullinated peptides are internalized by FLS through a RAGE-TLR9 pathway promoting FLS inflammatory phenotype and their upregulation of MHC class II. Once internalized, arthritogenic citrullinated NET-peptides are loaded into FLS MHC class II and presented to Ag-specific T cells. HLADRB1*0401 transgenic mice immunized with mouse FLS loaded with NETs develop cartilage damage as well as ACPAs specific to citrullinated forms of relevant RA autoantigens implicated in disease pathogenesis.

Conclusion:   These results suggest that NETs are a source of arthritogenic peptides in the synovium and implicate FLS as mediators in RA pathogenesis, through the internalization and presentation of citrullinated peptides to the adaptive immune system leading to pathogenic autoimmunity and cartilage damage.


Disclosure: C. Carmona-Rivera, None; E. Moore, None; N. Lingampalli, None; H. Uchtenhagen, None; E. James, None; K. L. Bicker, Rh-PG probe, 9; H. Wähämaa, None; V. Hoffmann, None; A. I. Catrina, None; P. Thompson, Padlock Therapeutics, 1,Janssen Pharmaceutica Product, L.P. and Padlock Therapeutics, 2,Padlock Therapeutics, 5,Padlock Therapeutics, 6; J. H. Buckner, None; W. Robinson, None; D. Fox, None; M. Kaplan, None.

To cite this abstract in AMA style:

Carmona-Rivera C, Moore E, Lingampalli N, Uchtenhagen H, James E, Bicker KL, Wähämaa H, Hoffmann V, Catrina AI, Thompson P, Buckner JH, Robinson W, Fox D, Kaplan M. Synovial Fibroblast-Neutrophil Interactions Promote Pathogenic Adaptive Immunity in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/synovial-fibroblast-neutrophil-interactions-promote-pathogenic-adaptive-immunity-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-fibroblast-neutrophil-interactions-promote-pathogenic-adaptive-immunity-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology